CytoSorb therapy for sepsis

This medtech innovation briefing (MIB) covers CytoSorb therapy for sepsis. It is an extracorporeal blood purification device that can be used to lower cytokine levels in the blood.The innovative aspects are that it is the only CE-marked device designed to lower excessive cytokines, which has the potential to control the excessive inflammatory response and reduce complications.The intended place in therapy would be as an addition to standard treatments, which may include renal replacement therapy, for people with sepsis or septic shock.

Source: Current Awareness Service for Health (CASH) - December 1, 2016 Category: Consumer Health News Source Type: news